The impact of ciprofol on early postoperative renal function in patients with renal impairment

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076256

Enrollment

Unknown

Registered

2023-09-28

Start date

2023-10-01

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Selective surgery

Interventions

control group:propofol

test group:cipofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 65 2. ASA grade I to III 3. General anesthesia 4.BMI < 30kg/m2 5.Impaired renal function (GFR < 60ml/min.1.73m2) 6.Patient and their family members have signed informed consent for anesthesia

Exclusion criteria

Exclusion criteria: 1.Severe preoperative cardiopulmonary insufficiency, infectious diseases, presence of infection and dehydration factors 2.Difficult airway 3.Severe systemic diseases 4.Cognitive dysfunction, delirium, epilepsy and mental disorders, or family history of these diseases 5.Long-term use of opioids, sedative drugs and drugs for psychiatric disorders

Design outcomes

Primary

Measure	Time frame
vital signs;Kidney injury markers;	—

Secondary

Measure	Time frame
Adverse event rate;	—

Countries

China

Contacts

Public ContactLi Jiyuan

Shunde Hospital of Southern Medical University

Leslie_Lee068@163.com+86 139 2489 2016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026